DONG-A ST CO.,LTD Logo

DONG-A ST CO.,LTD

Develops, manufactures, and markets drugs, medical devices, and diagnostics.

170900 | KO

Overview

Corporate Details

ISIN(s):
KR7170900005
LEI:
Country:
South Korea
Address:
서울 동대문구 용두동 138 ~255 천호대로 64, 서울

Description

Dong-A ST CO., LTD. is a pharmaceutical company focused on the research, development, manufacturing, and marketing of ethical drugs, medical devices, and diagnostics. The company's portfolio includes proprietary new drugs such as Stillen (gastritis), Zydena (erectile dysfunction), and Motilitone (functional dyspepsia). Operating from cGMP-compliant facilities, it exports a diverse range of products, including novel drugs, generics, and biopharmaceuticals, to global markets. The company maintains a strong commitment to innovative R&D, with a pipeline featuring first-in-class therapeutic candidates for metabolic diseases, including MASH (Metabolic dysfunction-associated steatohepatitis) and obesity, which are being advanced through a dedicated global R&D base.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-08-07 00:00
투자판단관련주요경영사항
Korean 11.2 KB
2024-08-07 00:00
최대주주등소유주식변동신고서
Korean 57.9 KB
2024-08-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.1 KB
2024-07-25 00:00
영업(잠정)실적(공정공시)
Korean 13.8 KB
2024-07-25 00:00
기업설명회(IR)개최(안내공시)
Korean 6.6 KB
2024-07-22 00:00
결산실적공시예고(안내공시)
Korean 4.1 KB
2024-07-22 00:00
기업설명회(IR)개최(안내공시)
Korean 6.8 KB
2024-07-02 00:00
최대주주등소유주식변동신고서
Korean 71.5 KB
2024-07-02 00:00
주식등의대량보유상황보고서(일반)
Korean 201.3 KB
2024-07-02 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.6 KB
2024-07-02 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 20.8 KB
2024-07-02 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 20.8 KB
2024-06-28 00:00
주주총회소집결의
Korean 9.0 KB
2024-06-28 00:00
주주총회소집공고
Korean 70.8 KB
2024-06-28 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.5 KB

Automate Your Workflow. Get a real-time feed of all DONG-A ST CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DONG-A ST CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DONG-A ST CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BIO-FD&C CO.,LTD. Logo
Develops active ingredients for cosmetics and pharma using a plant cell platform technology.
South Korea
251120
Biofrontera AG Logo
Biopharmaceutical firm specializing in photodynamic therapy for skin conditions.
Germany
B8F
Biofrontera Inc. Logo
A biopharmaceutical company commercializing products for dermatological conditions.
United States of America
BFRI
BioGaia Logo
A healthcare and biotechnology company developing clinically proven probiotic products.
Sweden
BIOG
BIOGEN INC. Logo
Biotechnology company developing therapies for neurological and neurodegenerative diseases.
United States of America
BIIB
Bio Green Med Solution, Inc. Logo
A diversified company in the biopharmaceutical and fire safety sectors.
United States of America
BGMS
BIOHARVEST SCIENCES INC. Logo
A biotech firm using a platform to grow plant cells for health and wellness products.
United States of America
BHST
Biohaven Ltd. Logo
Develops therapies for neuroscience, immunology, and oncology for unmet medical needs.
United States of America
BHVN
BioInvent International Logo
Develops novel, first-in-class immuno-modulatory antibodies for cancer therapy.
Sweden
BINV
BIOLIFE SOLUTIONS INC Logo
Manufactures biopreservation media and tools for cell and gene therapy markets.
United States of America
BLFS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.